CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

Harnessing Big Data to Accelerate Clinical...

Leigh Householder, Executive Vice President,...

How Can Artificial Intelligence Improve...

Jorine Putter, Head of Advanced Analytics at...

The Evolving Internet of Things (IoT) in...

Jerry Power, Executive Director, Institute for...

Aligning IT with the Cadence of your Business

William Leonard, ScD, Chief Information Officer, MPI...

Biopharma Start-Ups and the Development of...

Ulrich Geilinger, Venture Capitalist, HBM Partners AG

Data Governance is Relatively New to the...

William Phillips,SVP & CIO,University Health System

PCR Biosystems Launches a Range of IsoFast...

Jeremy Williams, Life Science Review

Navigo Proteins and Eleva Announce...

Jeremy Williams, Life Science Review

Harnessing Big Data to Accelerate Clinical...

Leigh Householder, Executive Vice President,...

How Can Artificial Intelligence Improve...

Jorine Putter, Head of Advanced Analytics at...

The Evolving Internet of Things (IoT) in...

Jerry Power, Executive Director, Institute for...

Aligning IT with the Cadence of your Business

William Leonard, ScD, Chief Information Officer, MPI...

Biopharma Start-Ups and the Development of...

Ulrich Geilinger, Venture Capitalist, HBM Partners AG

Data Governance is Relatively New to the...

William Phillips,SVP & CIO,University Health System

PCR Biosystems Launches a Range of IsoFast...

Jeremy Williams, Life Science Review

Navigo Proteins and Eleva Announce...

Jeremy Williams, Life Science Review

Future Predictive Analytics Solutions need the Right Level of Regulatory Governance

Frank Wang, System Vice President, IDN Decision Support Analytics, Health First
Tweet

In the past more than a decade or so, big data and predictive analytics has enjoyed the encouraging development and growth environment. The impact of the big data and predictive analytics to our daily lives is tremendous. Big data and predictive analytics is part of a business operation process and crucial to the outcome from targeted marketing to clinical interventions and recommending treatment pathways. The dynamic, independent, developer centric and open source style for developing the logic/algorithm for implementing the big data and predictive analytics solutions generates some scale of variations and confusions regarding to the predictive model build and the predicted outcomes. It is anticipated that the future predictive analytics solutions need the right level of regulatory governance in the following seven major areas in order to continuing grow smoothly.


"As a provider of analytics solutions or a data science team in an organization, it is important to take proactive approach to adopt the best practices in the development life cycle"


1. Share the purpose and motivation for using a specific algorithm to help building the trust and understanding of the analytical insights when adopting an analytics solution. To reduce the “black box” barrier on the end user side will help to utilize the business users’ expertise in the process improvement and improve the buy-in status from the end users. The impacted individuals need to be aware of why and how an analytics solution is used in the decision-making process.


2. Standardize the data partition in the whole development life cycle of model development, validation and testing. An industry standard for testing and valid an analytics performance needs to be adopted by data scientists. The approach for choosing the data for building a model validate a model and test a model greatly affect the precision for the prediction.


3. Make it transparent of what data is used in the analytics solution and how the data is collected and used. To explain to the consumers of an analytics solution how a data set is used will help to build trust and reach the outcome as expected. This is crucial for building the coordination between the impacted entities.


4. Authorized agencies need to help and assess the fundamental crucial features and core performance measures of an analytics system. For example, FDA need to work with the industries to provide the clinical decision support analytics guidelines.


5. Standardize the analytics system trial and validation process. The feedback loop for analytics solutions is relatively long, especially for healthcare predictive analytics solutions. It will take very long time to validate the predicted clinical outcomes in healthcare industry. A standard trial protocol needs to be agreed and followed for developing predictive analytics solutions.


6. Publish and share the performance data for major commercial analytics solutions. The authorized agencies need to maintain and share the standard performance measures for the analytics solutions to help the uses to assess the predictive modeling methodologies and pick the proper solutions.


7. Set up a center for testing the commercial analytics solution, guided by the authorized agencies. To share and public the standard performance by the center will help the users to select the right solutions as addition to their analytics tool kit.


As a provider of analytics solutions or a data science team in an organization, it is important to take proactive approach to adopt the best practices in the development life cycle to be prepared in the seven areas discussed. We will have a more detail discussion in a separate article.


Weekly Brief

loading
Top 10 Bioanalytical Services Companies in Europe - 2021
Top 5 Bioanalytical Service Companies In Uk – 2021
Top 5 Emerging Bioanalytical Services Companies in UK and Europe - 2021
Top 10 Bioanalytical Services Companies in Europe - 2021
Top 5 Bioanalytical Service Companies In Uk – 2021
Top 5 Emerging Bioanalytical Services Companies in UK and Europe - 2021
> <
  • Bioanalytical Services Europe 2021

    Top Vendors

    Current Issue
  • Bioanalytical Services Europe 2021

    Top Vendors

    Current Issue

Read Also

How Small Pharma, Working Within a Global Pharma, Can Benefit From One Pharmacovigilance System

Mai Huang, M.D., Executive Director, Drug Safety and Pharmacovigilance, Avanir Pharmaceuticals
How Small Pharma, Working Within a Global Pharma, Can Benefit From One Pharmacovigilance System

From ideation to portfolio program: Innovation vs validation in early drug discovery

Carlos Pedraza, PhD. Director of CNS Biology, Alkermes
From ideation to portfolio program: Innovation vs validation in early drug discovery

Analytics as a competitive advantage takes 3 things - access, cleanliness, and action

Matt Southwick, Executive Director Clinical Systems and Analytical Reporting, Amgen
Analytics as a competitive advantage takes 3 things - access, cleanliness, and action

Analytical Considerations for Combination Products

Jennifer L. Riter, Sr. Director, Analytical Services, West Pharmaceutical Services, Inc.
Analytical Considerations for Combination Products
An open Innovation Approach Applied to the Pharmaceutical Industry

An open Innovation Approach Applied to the Pharmaceutical Industry

Federico Piutti, Innovation Manager, Bormioli Pharma
The Pharma Tech Landscape under the New Normal

The Pharma Tech Landscape under the New Normal

Dusan Ruzic, Director, External Manufacturing, Merck

How CMOs/CDMOs can Add Value for Pharma Companies

Ozgur Akbulut, Director - Global Divestments and Contract Manufacturing Lead, Takeda
How CMOs/CDMOs can Add Value for Pharma Companies

Avoiding the 'Shiny object' Trap of Digital Transformation

Timothy White, Vice President & Head of Global Digital Commercial, Teva Pharmaceuticals
Avoiding the 'Shiny object' Trap of Digital Transformation
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://bioanalytical-services-europe.lifesciencesreview.com/cxoinsight/future-predictive-analytics-solutions-need-the-right-level-of-regulatory-governance-nwid-320.html